Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
about
Treatment of advanced squamous cell carcinoma of the lung: a reviewFGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell CancersFibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review.Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung CancerAcquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expressionThe Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published DataThe prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer.FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal CarcinomaTargeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis.FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models.Current and future molecular diagnostics in non-small-cell lung cancer.MET overexpression and gene amplification: prevalence, clinico-pathological characteristics and prognostic significance in a large cohort of patients with surgically resected NSCLC.Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.Advances and challenges in targeting FGFR signalling in cancer.Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer.An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.A sarcoidosis-like granuloma reaction in the lymph nodes of a patient with lung squamous cancer: from stasis to the invasive phase with FGFR1 gene amplification.A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer.Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma.FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance.FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis.[Relationship between FGFR1 Gene Regulation of Circulating Tumor Cells and Clinical Features of Non-small Cell Lung Cancer].[Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.A novel FGFR1-binding peptide exhibits anti-tumor effect on lung cancer by inhibiting proliferation and angiogenesis
P2860
Q26775392-87A9C78A-89E6-42B2-B4F4-D97D23061252Q27853171-3E134F99-7E8E-496C-A7F2-DEAE8F8704E5Q27853178-5855C431-AF08-455E-BBB2-4225BE036A18Q28077032-9CB65AE8-8D70-40AE-B42B-9BEFDFB73575Q30365571-CA1B3DC2-6348-42EB-BE27-D723AED16A0FQ31038314-48DFF046-2CA7-47A3-AFE2-BB3F8C9BCF00Q35659865-64010636-5EB3-4AAA-BD2C-9E4F862247A6Q35837391-A1A470D5-1045-44DE-B923-6ED2B4ACBEE0Q35881055-7F01899C-2EB3-4882-9ECC-43D52F68EC84Q36450685-19A39DFC-FA20-4A36-B33B-C7459400346EQ36983860-32AE5ED5-D40A-46E5-BD92-6A4EDB2C885AQ37457590-26C13347-63F9-48ED-BF5C-29C1A770DD99Q37515231-A2F9046B-CB55-4E11-85B0-38A117147629Q38543780-6795B625-2682-4ADD-A55B-496C98EB9F3EQ38681378-05C7765B-5263-4BD6-B495-563A8B0CF3FDQ38773668-458F6E7A-7966-4F32-8AB7-60B9834357FCQ39183442-EC8DD34D-FA14-4EEF-9967-1032D8F5E35AQ39226762-2CD10CDF-B854-481D-9676-F6698933C7B2Q40417660-94EB1BCE-DC9D-4973-8615-AB3E4EB11D14Q47141559-6E3901A1-71E6-42FE-B59F-2A8E4DEE63A9Q51636297-9F1CFE77-95BC-455F-ACE5-2C7A418695EFQ52766440-AE09EF58-9EB7-4E0E-85D6-0947EBCECE0AQ53098448-49D1B13B-9294-4649-9921-E2311895D3FFQ53227868-1E19C6D9-F78A-4645-BA83-F2CEAE652ABBQ54964630-C741E6C1-311B-4964-B281-88BCB3E34131Q54994574-7FB4C680-FE17-492C-B1A2-212EE4146423Q55440995-1444E576-52D6-4743-8644-447FF6D96EDFQ55443707-9E5A3DCB-9B9F-42D6-93C9-FE17CB814154Q55473120-0DD46F7B-6FFF-447A-8994-5C86C2B35097Q56888932-94721C07-21E2-49BD-B1C1-EFEB4DCA1B1A
P2860
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
@ast
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
@en
type
label
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
@ast
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
@en
prefLabel
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
@ast
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
@en
P2093
P2860
P356
P1476
Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
@en
P2093
D Lardinois
I Ackermann
L Bubendorf
M Bichsel-Naef
R A Schmid
S Schneider
P2860
P2888
P304
P356
10.1038/BJC.2014.229
P407
P577
2014-05-22T00:00:00Z
P5875
P6179
1035346398